Filtros : "STORPIRTIS, SILVIA" "Estados Unidos" Limpar

Filtros



Refine with date range


  • Source: Research in Social and Administrative Pharmacy. Unidade: FCF

    Assunto: MEDICAMENTO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LIMA, Tácio de Mendonça e AGUIAR, Patrícia Melo e STORPIRTIS, Silvia. Response letter to the editor Development and validation of key performance indicators for medication management services provided for outpatients". Research in Social and Administrative Pharmacy. New York: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.sapharm.2019.12.017. Acesso em: 05 out. 2024. , 2020
    • APA

      Lima, T. de M., Aguiar, P. M., & Storpirtis, S. (2020). Response letter to the editor Development and validation of key performance indicators for medication management services provided for outpatients". Research in Social and Administrative Pharmacy. New York: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.1016/j.sapharm.2019.12.017
    • NLM

      Lima T de M, Aguiar PM, Storpirtis S. Response letter to the editor Development and validation of key performance indicators for medication management services provided for outpatients" [Internet]. Research in Social and Administrative Pharmacy. 2020 ; 16( 3): 434-435.[citado 2024 out. 05 ] Available from: https://doi.org/10.1016/j.sapharm.2019.12.017
    • Vancouver

      Lima T de M, Aguiar PM, Storpirtis S. Response letter to the editor Development and validation of key performance indicators for medication management services provided for outpatients" [Internet]. Research in Social and Administrative Pharmacy. 2020 ; 16( 3): 434-435.[citado 2024 out. 05 ] Available from: https://doi.org/10.1016/j.sapharm.2019.12.017
  • Source: Research in Social and Administrative Pharmacy. Unidade: FCF

    Assunto: MEDICAMENTO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LIMA, Tácio de Mendonça e AGUIAR, Patricia Melo e STORPIRTIS, Silvia. Development and validation of key performance indicators for medication management services provided for outpatients. Research in Social and Administrative Pharmacy, v. 15, n. 9, p. 1080-1087, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.sapharm.2018.09.010. Acesso em: 05 out. 2024.
    • APA

      Lima, T. de M., Aguiar, P. M., & Storpirtis, S. (2019). Development and validation of key performance indicators for medication management services provided for outpatients. Research in Social and Administrative Pharmacy, 15( 9), 1080-1087. doi:10.1016/j.sapharm.2018.09.010
    • NLM

      Lima T de M, Aguiar PM, Storpirtis S. Development and validation of key performance indicators for medication management services provided for outpatients [Internet]. Research in Social and Administrative Pharmacy. 2019 ; 15( 9): 1080-1087.[citado 2024 out. 05 ] Available from: https://doi.org/10.1016/j.sapharm.2018.09.010
    • Vancouver

      Lima T de M, Aguiar PM, Storpirtis S. Development and validation of key performance indicators for medication management services provided for outpatients [Internet]. Research in Social and Administrative Pharmacy. 2019 ; 15( 9): 1080-1087.[citado 2024 out. 05 ] Available from: https://doi.org/10.1016/j.sapharm.2018.09.010
  • Source: Journal of Patient Experience. Unidade: FCF

    Subjects: NEOPLASIAS PROSTÁTICAS, ASSISTÊNCIA À SAÚDE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SCARABELIN, Aline et al. Pharmacist patient communication in prostate cancer as a strategy to humanize health hare: a qualitative study. Journal of Patient Experience, v. 6, n. 2, p. 150-156, 2019Tradução . . Disponível em: https://doi.org/10.1177/2374373518786508. Acesso em: 05 out. 2024.
    • APA

      Scarabelin, A., Dósea, A. S., Aguiar, P. M., & Storpirtis, S. (2019). Pharmacist patient communication in prostate cancer as a strategy to humanize health hare: a qualitative study. Journal of Patient Experience, 6( 2), 150-156. doi:10.1177/2374373518786508
    • NLM

      Scarabelin A, Dósea AS, Aguiar PM, Storpirtis S. Pharmacist patient communication in prostate cancer as a strategy to humanize health hare: a qualitative study [Internet]. Journal of Patient Experience. 2019 ; 6( 2): 150-156.[citado 2024 out. 05 ] Available from: https://doi.org/10.1177/2374373518786508
    • Vancouver

      Scarabelin A, Dósea AS, Aguiar PM, Storpirtis S. Pharmacist patient communication in prostate cancer as a strategy to humanize health hare: a qualitative study [Internet]. Journal of Patient Experience. 2019 ; 6( 2): 150-156.[citado 2024 out. 05 ] Available from: https://doi.org/10.1177/2374373518786508
  • Source: Journal of Evaluation in Clinical Practice. Unidades: IME, HU, FCF

    Subjects: DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, FARMACÊUTICOS, MULTIDISCIPLINARIDADE

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      AGUIAR, Patrícia Melo et al. Pharmacist-physician collaborative care model for patients with uncontrolled type 2 diabetes in Brazil: results from a randomized controlled trial. Journal of Evaluation in Clinical Practice, v. 24, n. 1, p. 22-30, 2018Tradução . . Disponível em: https://doi.org/10.1111/jep.12606. Acesso em: 05 out. 2024.
    • APA

      Aguiar, P. M., Silva, C. H. P. da, Chiann, C., Dórea, E. L., Lyra Júnior, D. P. de, & Storpirtis, S. (2018). Pharmacist-physician collaborative care model for patients with uncontrolled type 2 diabetes in Brazil: results from a randomized controlled trial. Journal of Evaluation in Clinical Practice, 24( 1), 22-30. doi:10.1111/jep.12606
    • NLM

      Aguiar PM, Silva CHP da, Chiann C, Dórea EL, Lyra Júnior DP de, Storpirtis S. Pharmacist-physician collaborative care model for patients with uncontrolled type 2 diabetes in Brazil: results from a randomized controlled trial [Internet]. Journal of Evaluation in Clinical Practice. 2018 ; 24( 1): 22-30.[citado 2024 out. 05 ] Available from: https://doi.org/10.1111/jep.12606
    • Vancouver

      Aguiar PM, Silva CHP da, Chiann C, Dórea EL, Lyra Júnior DP de, Storpirtis S. Pharmacist-physician collaborative care model for patients with uncontrolled type 2 diabetes in Brazil: results from a randomized controlled trial [Internet]. Journal of Evaluation in Clinical Practice. 2018 ; 24( 1): 22-30.[citado 2024 out. 05 ] Available from: https://doi.org/10.1111/jep.12606
  • Source: Research in Social and Administrative Pharmacy. Unidade: FCF

    Subjects: SERVIÇOS DE SAÚDE, PSICOMETRIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LIMA, Tácio de Mendonça e AGUIAR, Patrícia Melo e STORPIRTIS, Silvia. Evaluation of quality indicator instruments for pharmaceutical care services: a systematic review and psychometric properties analysis. Research in Social and Administrative Pharmacy, v. 14, n. 5, p. 405-412, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.sapharm.2017.05.011. Acesso em: 05 out. 2024.
    • APA

      Lima, T. de M., Aguiar, P. M., & Storpirtis, S. (2018). Evaluation of quality indicator instruments for pharmaceutical care services: a systematic review and psychometric properties analysis. Research in Social and Administrative Pharmacy, 14( 5), 405-412. doi:10.1016/j.sapharm.2017.05.011
    • NLM

      Lima T de M, Aguiar PM, Storpirtis S. Evaluation of quality indicator instruments for pharmaceutical care services: a systematic review and psychometric properties analysis [Internet]. Research in Social and Administrative Pharmacy. 2018 ; 14( 5): 405-412.[citado 2024 out. 05 ] Available from: https://doi.org/10.1016/j.sapharm.2017.05.011
    • Vancouver

      Lima T de M, Aguiar PM, Storpirtis S. Evaluation of quality indicator instruments for pharmaceutical care services: a systematic review and psychometric properties analysis [Internet]. Research in Social and Administrative Pharmacy. 2018 ; 14( 5): 405-412.[citado 2024 out. 05 ] Available from: https://doi.org/10.1016/j.sapharm.2017.05.011
  • Source: Critical Reviews in Oncology Hematology. Unidade: FCF

    Subjects: MIELOMA MÚLTIPLO, ANTINEOPLÁSICOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      AGUIAR, Patrícia Melo et al. Efficacy and safety of bortezomib, thalidomide, and lenalidomide in multiple myeloma: an overview of systematic reviews with meta-analyses. Critical Reviews in Oncology Hematology, v. 113, p. 195-212, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.critrevonc.2017.03.014. Acesso em: 05 out. 2024.
    • APA

      Aguiar, P. M., Lima, T. de M., Colleoni, G. W. B., & Storpirtis, S. (2017). Efficacy and safety of bortezomib, thalidomide, and lenalidomide in multiple myeloma: an overview of systematic reviews with meta-analyses. Critical Reviews in Oncology Hematology, 113, 195-212. doi:10.1016/j.critrevonc.2017.03.014
    • NLM

      Aguiar PM, Lima T de M, Colleoni GWB, Storpirtis S. Efficacy and safety of bortezomib, thalidomide, and lenalidomide in multiple myeloma: an overview of systematic reviews with meta-analyses [Internet]. Critical Reviews in Oncology Hematology. 2017 ; 113 195-212.[citado 2024 out. 05 ] Available from: https://doi.org/10.1016/j.critrevonc.2017.03.014
    • Vancouver

      Aguiar PM, Lima T de M, Colleoni GWB, Storpirtis S. Efficacy and safety of bortezomib, thalidomide, and lenalidomide in multiple myeloma: an overview of systematic reviews with meta-analyses [Internet]. Critical Reviews in Oncology Hematology. 2017 ; 113 195-212.[citado 2024 out. 05 ] Available from: https://doi.org/10.1016/j.critrevonc.2017.03.014
  • Source: Journal of Clinical Pharmacy and Therapeutics. Unidade: FCF

    Subjects: MIELOMA MÚLTIPLO, ANTINEOPLÁSICOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      AGUIAR, Patrícia Melo e LIMA, T M e STORPIRTIS, Silvia. Systematic review of the economic evaluations of novel therapeutic agents in multiple myeloma: what is the reporting quality?. Journal of Clinical Pharmacy and Therapeutics, v. 41, n. 2, p. 189-197, 2016Tradução . . Disponível em: https://doi.org/10.1111/jcpt.12384. Acesso em: 05 out. 2024.
    • APA

      Aguiar, P. M., Lima, T. M., & Storpirtis, S. (2016). Systematic review of the economic evaluations of novel therapeutic agents in multiple myeloma: what is the reporting quality? Journal of Clinical Pharmacy and Therapeutics, 41( 2), 189-197. doi:10.1111/jcpt.12384
    • NLM

      Aguiar PM, Lima TM, Storpirtis S. Systematic review of the economic evaluations of novel therapeutic agents in multiple myeloma: what is the reporting quality? [Internet]. Journal of Clinical Pharmacy and Therapeutics. 2016 ; 41( 2): 189-197.[citado 2024 out. 05 ] Available from: https://doi.org/10.1111/jcpt.12384
    • Vancouver

      Aguiar PM, Lima TM, Storpirtis S. Systematic review of the economic evaluations of novel therapeutic agents in multiple myeloma: what is the reporting quality? [Internet]. Journal of Clinical Pharmacy and Therapeutics. 2016 ; 41( 2): 189-197.[citado 2024 out. 05 ] Available from: https://doi.org/10.1111/jcpt.12384
  • Source: PLOS ONE. Unidade: FCF

    Subjects: GLICEMIA, DIABETES MELLITUS, ASSISTÊNCIA AO PACIENTE (SERVIÇOS DE SAÚDE), FARMACÊUTICOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      AGUIAR, Patrícia Melo et al. Investigating sources of heterogeneity in randomized controlled trials of the effects of pharmacist interventions on glycemic control in type 2 Diabetic Patients: a systematic review and meta-analysis. PLOS ONE, v. 11, n. 3, p. 1-23 art. e0150999, 2016Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0150999. Acesso em: 05 out. 2024.
    • APA

      Aguiar, P. M., Brito, G. de C., Lima, T. de M., Santos, A. P. A. L., Lyra Júnior, D. P. de, & Storpirtis, S. (2016). Investigating sources of heterogeneity in randomized controlled trials of the effects of pharmacist interventions on glycemic control in type 2 Diabetic Patients: a systematic review and meta-analysis. PLOS ONE, 11( 3), 1-23 art. e0150999. doi:10.1371/journal.pone.0150999
    • NLM

      Aguiar PM, Brito G de C, Lima T de M, Santos APAL, Lyra Júnior DP de, Storpirtis S. Investigating sources of heterogeneity in randomized controlled trials of the effects of pharmacist interventions on glycemic control in type 2 Diabetic Patients: a systematic review and meta-analysis [Internet]. PLOS ONE. 2016 ; 11( 3): 1-23 art. e0150999.[citado 2024 out. 05 ] Available from: https://doi.org/10.1371/journal.pone.0150999
    • Vancouver

      Aguiar PM, Brito G de C, Lima T de M, Santos APAL, Lyra Júnior DP de, Storpirtis S. Investigating sources of heterogeneity in randomized controlled trials of the effects of pharmacist interventions on glycemic control in type 2 Diabetic Patients: a systematic review and meta-analysis [Internet]. PLOS ONE. 2016 ; 11( 3): 1-23 art. e0150999.[citado 2024 out. 05 ] Available from: https://doi.org/10.1371/journal.pone.0150999
  • Source: Annals of Pharmacotherapy. Unidade: FCF

    Subjects: DIABETES MELLITUS, SERVIÇOS FARMACÊUTICOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      AGUIAR, Patrícia Melo et al. Exploring the quality of systematic reviews on pharmacist interventions in patients with diabetes: an overview. Annals of Pharmacotherapy, v. 48, n. 7, p. 887-896, 2014Tradução . . Disponível em: https://doi.org/10.1177/1060028014529411. Acesso em: 05 out. 2024.
    • APA

      Aguiar, P. M., Brito, G. de C., Correr, C. J., Lyra Júnior, D. P. de, & Storpirtis, S. (2014). Exploring the quality of systematic reviews on pharmacist interventions in patients with diabetes: an overview. Annals of Pharmacotherapy, 48( 7), 887-896. doi:10.1177/1060028014529411
    • NLM

      Aguiar PM, Brito G de C, Correr CJ, Lyra Júnior DP de, Storpirtis S. Exploring the quality of systematic reviews on pharmacist interventions in patients with diabetes: an overview [Internet]. Annals of Pharmacotherapy. 2014 ; 48( 7): 887-896.[citado 2024 out. 05 ] Available from: https://doi.org/10.1177/1060028014529411
    • Vancouver

      Aguiar PM, Brito G de C, Correr CJ, Lyra Júnior DP de, Storpirtis S. Exploring the quality of systematic reviews on pharmacist interventions in patients with diabetes: an overview [Internet]. Annals of Pharmacotherapy. 2014 ; 48( 7): 887-896.[citado 2024 out. 05 ] Available from: https://doi.org/10.1177/1060028014529411
  • Source: Journal of Pharmaceutical Sciences. Unidades: IME, FCF

    Subjects: BIOEQUIVALÊNCIA, SOLUBILIDADE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CRISTOFOLETTI, Rodrigo et al. A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies. Journal of Pharmaceutical Sciences, v. 102, n. 9, p. 3136-3144, 2013Tradução . . Disponível em: https://doi.org/10.1002/jps.23515. Acesso em: 05 out. 2024.
    • APA

      Cristofoletti, R., Chiann, C., Dressman, J. B., & Storpirtis, S. (2013). A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies. Journal of Pharmaceutical Sciences, 102( 9), 3136-3144. doi:10.1002/jps.23515
    • NLM

      Cristofoletti R, Chiann C, Dressman JB, Storpirtis S. A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies [Internet]. Journal of Pharmaceutical Sciences. 2013 ; 102( 9): 3136-3144.[citado 2024 out. 05 ] Available from: https://doi.org/10.1002/jps.23515
    • Vancouver

      Cristofoletti R, Chiann C, Dressman JB, Storpirtis S. A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies [Internet]. Journal of Pharmaceutical Sciences. 2013 ; 102( 9): 3136-3144.[citado 2024 out. 05 ] Available from: https://doi.org/10.1002/jps.23515
  • Source: Abstracts. Conference titles: Spring National Meeting and Exposition. Unidades: FCF, IFSC

    Subjects: PLANEJAMENTO DE FÁRMACOS, TRYPANOSOMA CRUZI, DOENÇA DE CHAGAS (ESTUDO;TRATAMENTO)

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      TROSSINI, Gustavo Henrique Goulart et al. Application of bioisosterism approach in the design, synthesis, and biological evaluation of nitrofurazone derivatives as antichagasic candidates. 2013, Anais.. Washington, DC: American Chemical Society - ACS, 2013. . Acesso em: 05 out. 2024.
    • APA

      Trossini, G. H. G., Arribas, M., Nishikawa, M., Gonçalves, J. E., Oliveira, T. F. de, Loureiro, A. P. de M., et al. (2013). Application of bioisosterism approach in the design, synthesis, and biological evaluation of nitrofurazone derivatives as antichagasic candidates. In Abstracts. Washington, DC: American Chemical Society - ACS.
    • NLM

      Trossini GHG, Arribas M, Nishikawa M, Gonçalves JE, Oliveira TF de, Loureiro AP de M, Storpirtis S, Krogh R, Andricopulo AD, Ferreira EI. Application of bioisosterism approach in the design, synthesis, and biological evaluation of nitrofurazone derivatives as antichagasic candidates. Abstracts. 2013 ;[citado 2024 out. 05 ]
    • Vancouver

      Trossini GHG, Arribas M, Nishikawa M, Gonçalves JE, Oliveira TF de, Loureiro AP de M, Storpirtis S, Krogh R, Andricopulo AD, Ferreira EI. Application of bioisosterism approach in the design, synthesis, and biological evaluation of nitrofurazone derivatives as antichagasic candidates. Abstracts. 2013 ;[citado 2024 out. 05 ]
  • Source: Biopharmaceutics & Drug Disposition. Unidades: IME, FCF

    Subjects: BIODISPONIBILIDADE, FARMACOCINÉTICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GONÇALVES, José Eduardo et al. Effect of pH, mucin and bovine serum on rifampicin permeability through Caco-2 cells. Biopharmaceutics & Drug Disposition, v. 33, n. 6, p. 316-323, 2012Tradução . . Disponível em: https://doi.org/10.1002/bdd.1802. Acesso em: 05 out. 2024.
    • APA

      Gonçalves, J. E., Fernandes, M. B., Chiann, C., Gai, M. N., Souza, J. de, & Storpirtis, S. (2012). Effect of pH, mucin and bovine serum on rifampicin permeability through Caco-2 cells. Biopharmaceutics & Drug Disposition, 33( 6), 316-323. doi:10.1002/bdd.1802
    • NLM

      Gonçalves JE, Fernandes MB, Chiann C, Gai MN, Souza J de, Storpirtis S. Effect of pH, mucin and bovine serum on rifampicin permeability through Caco-2 cells [Internet]. Biopharmaceutics & Drug Disposition. 2012 ; 33( 6): 316-323.[citado 2024 out. 05 ] Available from: https://doi.org/10.1002/bdd.1802
    • Vancouver

      Gonçalves JE, Fernandes MB, Chiann C, Gai MN, Souza J de, Storpirtis S. Effect of pH, mucin and bovine serum on rifampicin permeability through Caco-2 cells [Internet]. Biopharmaceutics & Drug Disposition. 2012 ; 33( 6): 316-323.[citado 2024 out. 05 ] Available from: https://doi.org/10.1002/bdd.1802
  • Source: Journal of Pharmaceutical Sciences. Unidade: FCF

    Subjects: ABSORÇÃO, FORMAS FARMACÊUTICAS, SOLUBILIDADE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SILVA, Arthur L. L et al. Biowaiver monographs for immediate-release solid oral dosage forms: stavudine. Journal of Pharmaceutical Sciences, v. 101, n. 1, p. 10-16, 2012Tradução . . Disponível em: https://doi.org/10.1002/jps.22756. Acesso em: 05 out. 2024.
    • APA

      Silva, A. L. L., Cristofoletti, R., Storpirtis, S., Sousa, V. D., Junginger, H. E., Shah, V. P., et al. (2012). Biowaiver monographs for immediate-release solid oral dosage forms: stavudine. Journal of Pharmaceutical Sciences, 101( 1), 10-16. doi:10.1002/jps.22756
    • NLM

      Silva ALL, Cristofoletti R, Storpirtis S, Sousa VD, Junginger HE, Shah VP, Stavchansky S, Dressman JB, Barends DM. Biowaiver monographs for immediate-release solid oral dosage forms: stavudine [Internet]. Journal of Pharmaceutical Sciences. 2012 ; 101( 1): 10-16.[citado 2024 out. 05 ] Available from: https://doi.org/10.1002/jps.22756
    • Vancouver

      Silva ALL, Cristofoletti R, Storpirtis S, Sousa VD, Junginger HE, Shah VP, Stavchansky S, Dressman JB, Barends DM. Biowaiver monographs for immediate-release solid oral dosage forms: stavudine [Internet]. Journal of Pharmaceutical Sciences. 2012 ; 101( 1): 10-16.[citado 2024 out. 05 ] Available from: https://doi.org/10.1002/jps.22756
  • Source: Revista Panamericana de Salud Pública. Unidade: FCF

    Assunto: MEDICAMENTO GENÉRICO (HISTÓRIA;LEGISLAÇÃO)

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ARAÚJO, Lorena Ulhôa et al. Medicamentos genéricos no Brasil: panorama histórico e legislação. Revista Panamericana de Salud Pública, v. 28, n. 6, p. 480-492, 2010Tradução . . Disponível em: https://doi.org/10.1590/s1020-49892010001200010. Acesso em: 05 out. 2024.
    • APA

      Araújo, L. U., Albuquerque, K. T. de, Kato, K. C., Silveira, G. S., Maciel, N. R., Spósito, P. Á., et al. (2010). Medicamentos genéricos no Brasil: panorama histórico e legislação. Revista Panamericana de Salud Pública, 28( 6), 480-492. doi:10.1590/s1020-49892010001200010
    • NLM

      Araújo LU, Albuquerque KT de, Kato KC, Silveira GS, Maciel NR, Spósito PÁ, Barcellos NMS, Souza J de, Bueno M, Storpirtis S. Medicamentos genéricos no Brasil: panorama histórico e legislação [Internet]. Revista Panamericana de Salud Pública. 2010 ; 28( 6): 480-492.[citado 2024 out. 05 ] Available from: https://doi.org/10.1590/s1020-49892010001200010
    • Vancouver

      Araújo LU, Albuquerque KT de, Kato KC, Silveira GS, Maciel NR, Spósito PÁ, Barcellos NMS, Souza J de, Bueno M, Storpirtis S. Medicamentos genéricos no Brasil: panorama histórico e legislação [Internet]. Revista Panamericana de Salud Pública. 2010 ; 28( 6): 480-492.[citado 2024 out. 05 ] Available from: https://doi.org/10.1590/s1020-49892010001200010
  • Source: Journal of Pharmaceutical Sciences. Unidade: FCF

    Subjects: BIODISPONIBILIDADE, GLICOPROTEÍNAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SOUZA, Jacqueline de e BENET, Leslie Z e STORPIRTIS, Silvia. Comparison of bidirectional lamivudine and zidovudine transport using MDCK, MDCK–MDR1, and caco-2 Cell monolayers. Journal of Pharmaceutical Sciences, v. 98, n. 11, p. 4413-4419, 2009Tradução . . Disponível em: https://doi.org/10.1002/jps.21744. Acesso em: 05 out. 2024.
    • APA

      Souza, J. de, Benet, L. Z., & Storpirtis, S. (2009). Comparison of bidirectional lamivudine and zidovudine transport using MDCK, MDCK–MDR1, and caco-2 Cell monolayers. Journal of Pharmaceutical Sciences, 98( 11), 4413-4419. doi:10.1002/jps.21744
    • NLM

      Souza J de, Benet LZ, Storpirtis S. Comparison of bidirectional lamivudine and zidovudine transport using MDCK, MDCK–MDR1, and caco-2 Cell monolayers [Internet]. Journal of Pharmaceutical Sciences. 2009 ; 98( 11): 4413-4419.[citado 2024 out. 05 ] Available from: https://doi.org/10.1002/jps.21744
    • Vancouver

      Souza J de, Benet LZ, Storpirtis S. Comparison of bidirectional lamivudine and zidovudine transport using MDCK, MDCK–MDR1, and caco-2 Cell monolayers [Internet]. Journal of Pharmaceutical Sciences. 2009 ; 98( 11): 4413-4419.[citado 2024 out. 05 ] Available from: https://doi.org/10.1002/jps.21744
  • Source: Journal of Thermal Analysis and Calorimetry. Unidades: FCF, IQ

    Subjects: ANÁLISE TÉRMICA, ZIDOVUDINA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ARAÚJO, Adriano Antunes de Souza et al. Effects of experimental conditions on the estimation of kinetic parameters of the thermal decomposition of AZT using factorial design. Journal of Thermal Analysis and Calorimetry, v. 79, n. 3, p. 697-701, 2005Tradução . . Acesso em: 05 out. 2024.
    • APA

      Araújo, A. A. de S., Cides, L. C. S., Storpirtis, S., Matos, J. do R., & Bruns, R. E. (2005). Effects of experimental conditions on the estimation of kinetic parameters of the thermal decomposition of AZT using factorial design. Journal of Thermal Analysis and Calorimetry, 79( 3), 697-701.
    • NLM

      Araújo AA de S, Cides LCS, Storpirtis S, Matos J do R, Bruns RE. Effects of experimental conditions on the estimation of kinetic parameters of the thermal decomposition of AZT using factorial design. Journal of Thermal Analysis and Calorimetry. 2005 ; 79( 3): 697-701.[citado 2024 out. 05 ]
    • Vancouver

      Araújo AA de S, Cides LCS, Storpirtis S, Matos J do R, Bruns RE. Effects of experimental conditions on the estimation of kinetic parameters of the thermal decomposition of AZT using factorial design. Journal of Thermal Analysis and Calorimetry. 2005 ; 79( 3): 697-701.[citado 2024 out. 05 ]
  • Unidade: FCF

    Subjects: TOXICOLOGIA, FARMACOLOGIA, INTOXICAÇÃO, FERRO

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      STORPIRTIS, Silvia e OLIVEIRA, Pedro Gonçalves de. Process for preparing a charcoal GM1 complex. . [S.l.]: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 05 out. 2024. , 2003
    • APA

      Storpirtis, S., & Oliveira, P. G. de. (2003). Process for preparing a charcoal GM1 complex. Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
    • NLM

      Storpirtis S, Oliveira PG de. Process for preparing a charcoal GM1 complex. 2003 ;[citado 2024 out. 05 ]
    • Vancouver

      Storpirtis S, Oliveira PG de. Process for preparing a charcoal GM1 complex. 2003 ;[citado 2024 out. 05 ]
  • Source: Journal of Inorganic Biochemistry. Unidades: IQ, FCF

    Subjects: QUÍMICA FARMACÊUTICA, FARMACOTÉCNICA, SÍNDROME DE IMUNODEFICIÊNCIA ADQUIRIDA, TERRAS RARAS, LUMINESCÊNCIA, ZIDOVUDINA

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ARAÚJO, Adriano Antunes de Souza et al. Synthesis and photophysical study of highly luminescent coordination compounds of rare earth ions with thenoyltrifluoroacetonate and AZT. Journal of Inorganic Biochemistry, v. 88, n. 1, p. 87-93, 2002Tradução . . Disponível em: https://doi.org/10.1016/s0162-0134(01)00346-4. Acesso em: 05 out. 2024.
    • APA

      Araújo, A. A. de S., Brito, H. F. de, Malta, O. L., Matos, J. do R., Teotonio, E. E. S., Storpirtis, S., & Izumi, C. M. S. (2002). Synthesis and photophysical study of highly luminescent coordination compounds of rare earth ions with thenoyltrifluoroacetonate and AZT. Journal of Inorganic Biochemistry, 88( 1), 87-93. doi:10.1016/s0162-0134(01)00346-4
    • NLM

      Araújo AA de S, Brito HF de, Malta OL, Matos J do R, Teotonio EES, Storpirtis S, Izumi CMS. Synthesis and photophysical study of highly luminescent coordination compounds of rare earth ions with thenoyltrifluoroacetonate and AZT [Internet]. Journal of Inorganic Biochemistry. 2002 ; 88( 1): 87-93.[citado 2024 out. 05 ] Available from: https://doi.org/10.1016/s0162-0134(01)00346-4
    • Vancouver

      Araújo AA de S, Brito HF de, Malta OL, Matos J do R, Teotonio EES, Storpirtis S, Izumi CMS. Synthesis and photophysical study of highly luminescent coordination compounds of rare earth ions with thenoyltrifluoroacetonate and AZT [Internet]. Journal of Inorganic Biochemistry. 2002 ; 88( 1): 87-93.[citado 2024 out. 05 ] Available from: https://doi.org/10.1016/s0162-0134(01)00346-4
  • Source: Analytical Letters. Unidade: FCF

    Assunto: ESPECTROFOTOMETRIA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SANTORO, Maria Inês Rocha Miritello et al. Spectrophotometric determination of chlorpromazine and levomepromazine hydrochlorides in injectables and drops by reaction with ferric ion. Analytical Letters, v. 22, n. 4, p. 929-949, 1989Tradução . . Acesso em: 05 out. 2024.
    • APA

      Santoro, M. I. R. M., Storpirtis, S., Kedor-Hackmann, E. R. M., & Magalhães, J. F. (1989). Spectrophotometric determination of chlorpromazine and levomepromazine hydrochlorides in injectables and drops by reaction with ferric ion. Analytical Letters, 22( 4), 929-949.
    • NLM

      Santoro MIRM, Storpirtis S, Kedor-Hackmann ERM, Magalhães JF. Spectrophotometric determination of chlorpromazine and levomepromazine hydrochlorides in injectables and drops by reaction with ferric ion. Analytical Letters. 1989 ; 22( 4): 929-949.[citado 2024 out. 05 ]
    • Vancouver

      Santoro MIRM, Storpirtis S, Kedor-Hackmann ERM, Magalhães JF. Spectrophotometric determination of chlorpromazine and levomepromazine hydrochlorides in injectables and drops by reaction with ferric ion. Analytical Letters. 1989 ; 22( 4): 929-949.[citado 2024 out. 05 ]
  • Source: Abstracts. Conference titles: Annual International Meeting of Association of Official Analytical Chemists. Unidade: FCF

    Subjects: CROMATOGRAFIA LÍQUIDA DE ALTA EFICIÊNCIA, FÁRMACOS

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SANTORO, Maria Inês Rocha Miritello e KEDOR-HACKMANN, Erika Rosa Maria e STORPIRTIS, Silvia. Determination of chlorpromazine hydrochloride in pharmaceutical preparations by hplc. 1989, Anais.. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, 1989. . Acesso em: 05 out. 2024.
    • APA

      Santoro, M. I. R. M., Kedor-Hackmann, E. R. M., & Storpirtis, S. (1989). Determination of chlorpromazine hydrochloride in pharmaceutical preparations by hplc. In Abstracts. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
    • NLM

      Santoro MIRM, Kedor-Hackmann ERM, Storpirtis S. Determination of chlorpromazine hydrochloride in pharmaceutical preparations by hplc. Abstracts. 1989 ;[citado 2024 out. 05 ]
    • Vancouver

      Santoro MIRM, Kedor-Hackmann ERM, Storpirtis S. Determination of chlorpromazine hydrochloride in pharmaceutical preparations by hplc. Abstracts. 1989 ;[citado 2024 out. 05 ]

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024